EHRs, Worth the Hassle? : ‘Meaningful use’ criteria can pose high hurdle for derms Allergan Settles : Drugmaker to pay $600 million to resolve off-label marketing charges Special Report : Hair & Nails
Expert Reflections: Impact of Dermatology Times
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Rituximab May Provide Alternative Treatment Option for Epidermolysis Bullosa Acquisita
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS